Tower Research Capital (TRC)’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.95K | Sell |
376
-13,540
| -97% | -$286K | ﹤0.01% | 4031 |
|
|
2025
Q1 | $295K | Sell |
13,916
-14,145
| -50% | -$300K | 0.01% | 1153 |
|
|
2024
Q4 | $604K | Buy |
28,061
+16,768
| +148% | +$361K | 0.01% | 932 |
|
|
2024
Q3 | $269K | Sell |
11,293
-1,417
| -11% | -$33.7K | 0.01% | 1352 |
|
|
2024
Q2 | $289K | Buy |
12,710
+12,641
| +18,320% | +$288K | ﹤0.01% | 1797 |
|
|
2024
Q1 | $1.53K | Sell |
69
-9,276
| -99% | -$206K | ﹤0.01% | 5250 |
|
|
2023
Q4 | $205K | Sell |
9,345
-3,840
| -29% | -$84.1K | ﹤0.01% | 2085 |
|
|
2023
Q3 | $261K | Sell |
13,185
-14,761
| -53% | -$293K | 0.01% | 1270 |
|
|
2023
Q2 | $571K | Buy |
27,946
+11,122
| +66% | +$227K | 0.02% | 876 |
|
|
2023
Q1 | $348K | Buy |
16,824
+2,618
| +18% | +$54.2K | 0.01% | 1049 |
|
|
2022
Q4 | $299K | Sell |
14,206
-23,443
| -62% | -$493K | 0.01% | 1021 |
|
|
2022
Q3 | $712K | Sell |
37,649
-5,415
| -13% | -$102K | 0.01% | 880 |
|
|
2022
Q2 | $811K | Sell |
43,064
-3,289
| -7% | -$61.9K | 0.02% | 825 |
|
|
2022
Q1 | $970K | Buy |
46,353
+28,787
| +164% | +$602K | 0.01% | 799 |
|
|
2021
Q4 | $417K | Buy |
17,566
+8,182
| +87% | +$194K | 0.01% | 1234 |
|
|
2021
Q3 | $240K | Sell |
9,384
-316,245
| -97% | -$8.09M | 0.01% | 1641 |
|
|
2021
Q2 | $8.44M | Buy |
+325,629
| New | +$8.44M | 0.22% | 63 |
|